Emmanuel Brouillet, PhD - Publications

Affiliations: 
Pharmacology University of Paris-Sud 11 (Orsay) 

143 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Vautheny A, Duwat C, Auregan G, Joséphine C, Hérard AS, Jan C, Mitja J, Gipchtein P, Gaillard MC, Buée L, Blum D, Hantraye P, Bonvento G, Brouillet E, Cambon K, et al. THY-Tau22 mouse model accumulates more tauopathy at late stage of the disease in response to microglia deactivation through TREM2 deficiency. Neurobiology of Disease. 105398. PMID 34019997 DOI: 10.1016/j.nbd.2021.105398  0.48
2021 Maté de Gérando A, d'Orange M, Augustin E, Joséphine C, Aurégan G, Gaudin-Guérif M, Guillermier M, Hérard AS, Stimmer L, Petit F, Gipchtein P, Jan C, Escartin C, Selingue E, Carvalho K, ... ... Brouillet E, et al. Neuronal tau species transfer to astrocytes and induce their loss according to tau aggregation state. Brain : a Journal of Neurology. PMID 33842937 DOI: 10.1093/brain/awab011  0.48
2020 Guillemaud O, Ceyzériat K, Saint-Georges T, Cambon K, Petit F, Ben Haim L, Carrillo-de Sauvage MA, Guillermier M, Bernier S, Hérard AS, Joséphine C, Bémelmans AP, Brouillet E, Hantraye P, Bonvento G, et al. Complex roles for reactive astrocytes in the triple transgenic mouse model of Alzheimer disease. Neurobiology of Aging. PMID 32171592 DOI: 10.1016/J.Neurobiolaging.2020.02.010  0.48
2020 Le Douce J, Maugard M, Veran J, Matos M, Jégo P, Vigneron PA, Faivre E, Toussay X, Vandenberghe M, Balbastre Y, Piquet J, Guiot E, Tran NT, Taverna M, Marinesco S, ... ... Brouillet E, et al. Impairment of Glycolysis-Derived l-Serine Production in Astrocytes Contributes to Cognitive Deficits in Alzheimer's Disease. Cell Metabolism. 31: 503-517.e8. PMID 32130882 DOI: 10.1016/J.Cmet.2020.02.004  0.48
2019 Cresto N, Gaillard MC, Gardier C, Gubinelli F, Diguet E, Bellet D, Legroux L, Mitja J, Auregan G, Guillermier M, Josephine C, Jan C, Dufour N, Joliot A, Hantraye P, ... ... Brouillet E, et al. The C-terminal domain of LRRK2 with the G2019S mutation is sufficient to produce neurodegeneration of dopaminergic neurons in vivo. Neurobiology of Disease. 104614. PMID 31605779 DOI: 10.1016/J.Nbd.2019.104614  0.48
2019 Ligneul C, Palombo M, Hernández-Garzón E, Carrillo-de Sauvage MA, Flament J, Hantraye P, Brouillet E, Bonvento G, Escartin C, Valette J. Diffusion-weighted magnetic resonance spectroscopy enables cell-specific monitoring of astrocyte reactivity in vivo. Neuroimage. 191: 457-469. PMID 30818026 DOI: 10.1016/J.Neuroimage.2019.02.046  0.48
2018 Ceyzériat K, Ben Haim L, Denizot A, Pommier D, Matos M, Guillemaud O, Palomares MA, Abjean L, Petit F, Gipchtein P, Gaillard MC, Guillermier M, Bernier S, Gaudin M, Aurégan G, ... ... Brouillet E, et al. Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer's disease. Acta Neuropathologica Communications. 6: 104. PMID 30322407 DOI: 10.1186/S40478-018-0606-1  0.48
2018 Galvan L, Francelle L, Gaillard MC, de Longprez L, Carrillo-de Sauvage MA, Liot G, Cambon K, Stimmer L, Luccantoni S, Flament J, Valette J, de Chaldée M, Auregan G, Guillermier M, Joséphine C, ... ... Brouillet E, et al. The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin. Brain : a Journal of Neurology. PMID 29534157 DOI: 10.1093/Brain/Awy057  0.48
2018 Senova S, Poupon C, Dauguet J, Stewart HJ, Dugué GP, Jan C, Hosomi K, Ralph GS, Barnes L, Drouot X, Pouzat C, Mangin JF, Pain F, Doignon I, Aron-Badin R, ... Brouillet E, et al. Optogenetic Tractography for anatomo-functional characterization of cortico-subcortical neural circuits in non-human primates. Scientific Reports. 8: 3362. PMID 29463867 DOI: 10.1038/S41598-018-21486-8  0.48
2018 Abjean L, Haim LB, Sauvage MAC, Hérard A, Derbois C, Petit F, Gipstein P, Guillermier M, Gaudin M, Bernier S, Dufour N, Bémelmans A, Deleuze J, Hantraye P, Bonvento G, ... ... Brouillet E, et al. A42 Reactive astrocytes promote proteostasis in huntington’s disease Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.40  0.48
2017 d'Orange M, Aurégan G, Cheramy D, Gaudin-Guérif M, Lieger S, Guillermier M, Stimmer L, Joséphine C, Hérard AS, Gaillard MC, Petit F, Kiessling MC, Schmitz C, Colin M, Buée L, ... ... Brouillet E, et al. Potentiating tangle formation reduces acute toxicity of soluble tau species in the rat. Brain : a Journal of Neurology. PMID 29253129 DOI: 10.1093/Brain/Awx342  0.48
2017 Merienne N, Vachey G, de Longprez L, Meunier C, Zimmer V, Perriard G, Canales M, Mathias A, Herrgott L, Beltraminelli T, Maulet A, Dequesne T, Pythoud C, Rey M, Pellerin L, ... Brouillet E, et al. The Self-Inactivating KamiCas9 System for the Editing of CNS Disease Genes. Cell Reports. 20: 2980-2991. PMID 28930690 DOI: 10.1016/J.Celrep.2017.08.075  0.36
2017 Francelle L, Lotz C, Outeiro T, Brouillet E, Merienne K. Contribution of Neuroepigenetics to Huntington's Disease. Frontiers in Human Neuroscience. 11: 17. PMID 28194101 DOI: 10.3389/Fnhum.2017.00017  0.36
2016 Galan-Rodriguez B, Martin E, Brouillet E, Déglon N, Betuing S, Caboche J. Coupling of d2R short but not d2R Long receptor isoform to the Rho/Rock signaling pathway renders striatal neurons vulnerable to mutant huntingtin. The European Journal of Neuroscience. PMID 27717053 DOI: 10.1111/Ejn.13415  0.36
2016 Pépin J, Francelle L, Carrillo-de Sauvage MA, de Longprez L, Gipchtein P, Cambon K, Valette J, Brouillet E, Flament J. In vivo imaging of brain glutamate defects in a knock-in mouse model of Huntington's disease. Neuroimage. 139: 53-64. PMID 27318215 DOI: 10.1016/J.Neuroimage.2016.06.023  0.36
2016 Palombo M, Ligneul C, Najac C, Le Douce J, Flament J, Escartin C, Hantraye P, Brouillet E, Bonvento G, Valette J. New paradigm to assess brain cell morphology by diffusion-weighted MR spectroscopy in vivo. Proceedings of the National Academy of Sciences of the United States of America. PMID 27226303 DOI: 10.1073/Pnas.1504327113  0.48
2016 Flament J, Pépin J, Francelle L, Sauvage MC, Longprez Ld, Gipchtein P, Cambon K, Valette J, Brouillet E. B40 In vivo imaging of brain glutamate defects in a knock-in mouse model of huntington’s disease Journal of Neurology, Neurosurgery, and Psychiatry. 87. DOI: 10.1136/Jnnp-2016-314597.71  0.36
2016 Ceyzeriat K, Haim LB, Saint-Georges T, Petit F, Houitte D, Guillermier M, Berniard A, Mitja J, Josephine C, Hantraye P, Brouillet E, Cambon K, Dhenain M, Bonvento G, Escartin C. Specific Inhibition Of Astrocyte Reactivity Improves Some Disease Outcomes In Alzheimer'S Disease Mice Alzheimers & Dementia. 12: 242. DOI: 10.1016/J.Jalz.2016.06.433  0.48
2015 Rocher AB, Gubellini P, Merienne N, Boussicault L, Petit F, Gipchtein P, Jan C, Hantraye P, Brouillet E, Bonvento G. Synaptic scaling up in medium spiny neurons of aged BACHD mice: A slow-progression model of Huntington's disease. Neurobiology of Disease. PMID 26626081 DOI: 10.1016/J.Nbd.2015.10.016  0.88
2015 Carrillo-de Sauvage MA, Flament J, Bramoulle Y, Ben Haim L, Guillermier M, Berniard A, Aurégan G, Houitte D, Brouillet E, Bonvento G, Hantraye P, Valette J, Escartin C. The neuroprotective agent CNTF decreases neuronal metabolites in the rat striatum: an in vivo multimodal magnetic resonance imaging study. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 35: 917-21. PMID 25833344 DOI: 10.1038/Jcbfm.2015.48  0.88
2015 Ben Haim L, Ceyzériat K, Carrillo-de Sauvage MA, Aubry F, Auregan G, Guillermier M, Ruiz M, Petit F, Houitte D, Faivre E, Vandesquille M, Aron-Badin R, Dhenain M, Déglon N, Hantraye P, ... Brouillet E, et al. The JAK/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer's and Huntington's diseases. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 2817-29. PMID 25673868 DOI: 10.1523/Jneurosci.3516-14.2015  0.88
2015 Francelle L, Galvan L, Gaillard MC, Petit F, Bernay B, Guillermier M, Bonvento G, Dufour N, Elalouf JM, Hantraye P, Déglon N, de Chaldée M, Brouillet E. The striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivo. Neurobiology of Aging. 36: 1601.e7-16. PMID 25619660 DOI: 10.1016/J.Neurobiolaging.2014.11.014  0.88
2015 Francelle L, Galvan L, Gaillard MC, Guillermier M, Houitte D, Bonvento G, Petit F, Jan C, Dufour N, Hantraye P, Elalouf JM, De Chaldée M, Déglon N, Brouillet E. Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's disease. Human Molecular Genetics. 24: 1563-73. PMID 25398949 DOI: 10.1093/Hmg/Ddu571  0.88
2015 Blum D, Herrera F, Francelle L, Mendes T, Basquin M, Obriot H, Demeyer D, Sergeant N, Gerhardt E, Brouillet E, Buée L, Outeiro TF. Mutant huntingtin alters Tau phosphorylation and subcellular distribution. Human Molecular Genetics. 24: 76-85. PMID 25143394 DOI: 10.1093/Hmg/Ddu421  0.88
2015 Roy M, Cardoso C, Dorieux O, Malgorn C, Epelbaum S, Petit F, Kraska A, Brouillet E, Delatour B, Perret M, Aujard F, Dhenain M. Age-associated evolution of plasmatic amyloid in mouse lemur primates: relationship with intracellular amyloid deposition. Neurobiology of Aging. 36: 149-56. PMID 25131002 DOI: 10.1016/J.Neurobiolaging.2014.07.017  0.88
2014 Francelle L, Galvan L, Brouillet E. Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease. Frontiers in Cellular Neuroscience. 8: 295. PMID 25309327 DOI: 10.3389/Fncel.2014.00295  0.88
2014 Dujardin S, Bégard S, Caillierez R, Lachaud C, Delattre L, Carrier S, Loyens A, Galas MC, Bousset L, Melki R, Aurégan G, Hantraye P, Brouillet E, Buée L, Colin M. Ectosomes: a new mechanism for non-exosomal secretion of tau protein. Plos One. 9: e100760. PMID 24971751 DOI: 10.1371/Journal.Pone.0100760  0.88
2014 Boussicault L, Hérard AS, Calingasan N, Petit F, Malgorn C, Merienne N, Jan C, Gaillard MC, Lerchundi R, Barros LF, Escartin C, Delzescaux T, Mariani J, Hantraye P, Beal MF, ... Brouillet E, et al. Impaired brain energy metabolism in the BACHD mouse model of Huntington's disease: critical role of astrocyte-neuron interactions. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 34: 1500-10. PMID 24938402 DOI: 10.1038/Jcbfm.2014.110  0.88
2014 Brouillet E. The 3-NP Model of Striatal Neurodegeneration. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. 67: 9.48.1-9.48.14. PMID 24723322 DOI: 10.1002/0471142301.Ns0948S67  0.88
2014 Najac C, Marchadour C, Guillermier M, Houitte D, Slavov V, Brouillet E, Hantraye P, Lebon V, Valette J. Intracellular metabolites in the primate brain are primarily localized in long fibers rather than in cell bodies, as shown by diffusion-weighted magnetic resonance spectroscopy. Neuroimage. 90: 374-80. PMID 24382523 DOI: 10.1016/J.Neuroimage.2013.12.045  0.88
2014 Facchinetti P, Dorard E, Contremoulins V, Gaillard MC, Déglon N, Sazdovitch V, Guihenneuc-Jouyaux C, Brouillet E, Duyckaerts C, Allinquant B. SET translocation is associated with increase in caspase cleaved amyloid precursor protein in CA1 of Alzheimer and Down syndrome patients. Neurobiology of Aging. 35: 958-68. PMID 24262202 DOI: 10.1016/J.Neurobiolaging.2013.08.039  0.88
2013 Damiano M, Diguet E, Malgorn C, D'Aurelio M, Galvan L, Petit F, Benhaim L, Guillermier M, Houitte D, Dufour N, Hantraye P, Canals JM, Alberch J, Delzescaux T, Déglon N, ... ... Brouillet E, et al. A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin. Human Molecular Genetics. 22: 3869-82. PMID 23720495 DOI: 10.1093/Hmg/Ddt242  0.88
2013 Charbord J, Poydenot P, Bonnefond C, Feyeux M, Casagrande F, Brinon B, Francelle L, Aurégan G, Guillermier M, Cailleret M, Viegas P, Nicoleau C, Martinat C, Brouillet E, Cattaneo E, et al. High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes. Stem Cells (Dayton, Ohio). 31: 1816-28. PMID 23712629 DOI: 10.1002/Stem.1430  0.88
2013 Aron Badin R, Spinnewyn B, Gaillard MC, Jan C, Malgorn C, Van Camp N, Dollé F, Guillermier M, Boulet S, Bertrand A, Savasta M, Auguet M, Brouillet E, Chabrier PE, Hantraye P. IRC-082451, a novel multitargeting molecule, reduces L-DOPA-induced dyskinesias in MPTP Parkinsonian primates. Plos One. 8: e52680. PMID 23300984 DOI: 10.1371/journal.pone.0052680  0.88
2012 Delzor A, Dufour N, Petit F, Guillermier M, Houitte D, Auregan G, Brouillet E, Hantraye P, Déglon N. Restricted transgene expression in the brain with cell-type specific neuronal promoters. Human Gene Therapy Methods. 23: 242-54. PMID 22934828 DOI: 10.1089/Hgtb.2012.073  0.88
2012 Marchadour C, Brouillet E, Hantraye P, Lebon V, Valette J. Anomalous diffusion of brain metabolites evidenced by diffusion-weighted magnetic resonance spectroscopy in vivo. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 2153-60. PMID 22929443 DOI: 10.1038/Jcbfm.2012.119  0.88
2012 Chaumeil MM, Valette J, Baligand C, Brouillet E, Hantraye P, Bloch G, Gaura V, Rialland A, Krystkowiak P, Verny C, Damier P, Remy P, Bachoud-Levi AC, Carlier P, Lebon V. pH as a biomarker of neurodegeneration in Huntington's disease: a translational rodent-human MRS study. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 771-9. PMID 22373643 DOI: 10.1038/Jcbfm.2012.15  0.88
2012 Galvan L, Lepejová N, Gaillard MC, Malgorn C, Guillermier M, Houitte D, Bonvento G, Petit F, Dufour N, Héry P, Gérard M, Elalouf JM, Déglon N, Brouillet E, de Chaldée M. Capucin does not modify the toxicity of a mutant Huntingtin fragment in vivo. Neurobiology of Aging. 33: 1845.e5-6. PMID 22365050 DOI: 10.1016/J.Neurobiolaging.2012.01.009  0.88
2012 Mochel F, Durant B, Meng X, O'Callaghan J, Yu H, Brouillet E, Wheeler VC, Humbert S, Schiffmann R, Durr A. Early alterations of brain cellular energy homeostasis in Huntington disease models. The Journal of Biological Chemistry. 287: 1361-70. PMID 22123819 DOI: 10.1074/Jbc.M111.309849  0.88
2011 Shin M, Jan C, Jacquard C, Jarraya B, Callebert J, Launay JM, Hantraye P, Remy P, Palfi S, Brouillet E. Chronic systemic treatment with a high-dose proteasome inhibitor in mice produces akinesia unrelated to nigrostriatal degeneration. Neurobiology of Aging. 32: 2100-2. PMID 20018410 DOI: 10.1016/J.Neurobiolaging.2009.11.015  0.88
2010 Faideau M, Kim J, Cormier K, Gilmore R, Welch M, Auregan G, Dufour N, Guillermier M, Brouillet E, Hantraye P, Déglon N, Ferrante RJ, Bonvento G. In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects. Human Molecular Genetics. 19: 3053-67. PMID 20494921 DOI: 10.1093/Hmg/Ddq212  0.88
2010 Escartin C, Brouillet E. The Nrf2 pathway as a potential therapeutic target for Huntington disease A commentary on "Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington disease". Free Radical Biology & Medicine. 49: 144-6. PMID 20399852 DOI: 10.1016/J.Freeradbiomed.2010.04.009  0.88
2010 Alves S, Nascimento-Ferreira I, Dufour N, Hassig R, Auregan G, Nóbrega C, Brouillet E, Hantraye P, Pedroso de Lima MC, Déglon N, de Almeida LP. Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3? Human Molecular Genetics. 19: 2380-94. PMID 20308049 DOI: 10.1093/Hmg/Ddq111  0.88
2010 Cleren C, Calingasan NY, Starkov A, Jacquard C, Chen J, Brouillet E, Beal MF. Promethazine protects against 3-nitropropionic acid-induced neurotoxicity. Neurochemistry International. 56: 208-12. PMID 19852992 DOI: 10.1016/J.Neuint.2009.10.006  0.88
2010 Damiano M, Galvan L, Déglon N, Brouillet E. Mitochondria in Huntington's disease. Biochimica Et Biophysica Acta. 1802: 52-61. PMID 19682570 DOI: 10.1016/J.Bbadis.2009.07.012  0.88
2009 Jarraya B, Boulet S, Ralph GS, Jan C, Bonvento G, Azzouz M, Miskin JE, Shin M, Delzescaux T, Drouot X, Hérard AS, Day DM, Brouillet E, Kingsman SM, Hantraye P, et al. Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesia. Science Translational Medicine. 1: 2ra4. PMID 20368163 DOI: 10.1126/Scitranslmed.3000130  0.88
2009 Drouet V, Perrin V, Hassig R, Dufour N, Auregan G, Alves S, Bonvento G, Brouillet E, Luthi-Carter R, Hantraye P, Déglon N. Sustained effects of nonallele-specific Huntingtin silencing. Annals of Neurology. 65: 276-85. PMID 19334076 DOI: 10.1002/Ana.21569  0.88
2009 Diguet E, Petit F, Escartin C, Cambon K, Bizat N, Dufour N, Hantraye P, Déglon N, Brouillet E. Normal aging modulates the neurotoxicity of mutant huntingtin. Plos One. 4: e4637. PMID 19247483 DOI: 10.1371/Journal.Pone.0004637  0.48
2009 Chaumeil MM, Valette J, Guillermier M, Brouillet E, Boumezbeur F, Herard AS, Bloch G, Hantraye P, Lebon V. Multimodal neuroimaging provides a highly consistent picture of energy metabolism, validating 31P MRS for measuring brain ATP synthesis. Proceedings of the National Academy of Sciences of the United States of America. 106: 3988-93. PMID 19234118 DOI: 10.1073/Pnas.0806516106  0.88
2009 Bernay B, Gaillard MC, Guryca V, Emadali A, Kuhn L, Bertrand A, Detraz I, Carcenac C, Savasta M, Brouillet E, Garin J, Elalouf JM. Discovering new bioactive neuropeptides in the striatum secretome using in vivo microdialysis and versatile proteomics. Molecular & Cellular Proteomics : McP. 8: 946-58. PMID 19164277 DOI: 10.1074/Mcp.M800501-Mcp200  0.88
2009 Sagredo O, González S, Aroyo I, Pazos MR, Benito C, Lastres-Becker I, Romero JP, Tolón RM, Mechoulam R, Brouillet E, Romero J, Fernández-Ruiz J. Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease. Glia. 57: 1154-67. PMID 19115380 DOI: 10.1002/Glia.20838  0.88
2009 Perrin V, Dufour N, Raoul C, Hassig R, Brouillet E, Aebischer P, Luthi-Carter R, Déglon N. Implication of the JNK pathway in a rat model of Huntington's disease. Experimental Neurology. 215: 191-200. PMID 19022249 DOI: 10.1016/J.Expneurol.2008.10.008  0.88
2009 Colin A, Faideau M, Dufour N, Auregan G, Hassig R, Andrieu T, Brouillet E, Hantraye P, Bonvento G, Déglon N. Engineered lentiviral vector targeting astrocytes in vivo. Glia. 57: 667-79. PMID 18942755 DOI: 10.1002/Glia.20795  0.88
2009 Galvan L, Brouillet E. Rhes, a protein with selective expression in the striatum, plays a major role in Huntington's disease pathogenesis Future Neurology. 4: 697-701. DOI: 10.2217/Fnl.09.46  0.88
2008 Alves S, Nascimento-Ferreira I, Auregan G, Hassig R, Dufour N, Brouillet E, Pedroso de Lima MC, Hantraye P, Pereira de Almeida L, Déglon N. Allele-specific RNA silencing of mutant ataxin-3 mediates neuroprotection in a rat model of Machado-Joseph disease. Plos One. 3: e3341. PMID 18841197 DOI: 10.1371/Journal.Pone.0003341  0.88
2008 Alves S, Régulier E, Nascimento-Ferreira I, Hassig R, Dufour N, Koeppen A, Carvalho AL, Simões S, de Lima MC, Brouillet E, Gould VC, Déglon N, de Almeida LP. Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease. Human Molecular Genetics. 17: 2071-83. PMID 18385100 DOI: 10.1093/Hmg/Ddn106  0.88
2008 Benchoua A, Trioulier Y, Diguet E, Malgorn C, Gaillard MC, Dufour N, Elalouf JM, Krajewski S, Hantraye P, Déglon N, Brouillet E. Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II. Human Molecular Genetics. 17: 1446-56. PMID 18267960 DOI: 10.1093/hmg/ddn033  0.88
2008 Brochier C, Gaillard MC, Diguet E, Caudy N, Dossat C, Ségurens B, Wincker P, Roze E, Caboche J, Hantraye P, Brouillet E, Elalouf JM, de Chaldée M. Quantitative gene expression profiling of mouse brain regions reveals differential transcripts conserved in human and affected in disease models. Physiological Genomics. 33: 170-9. PMID 18252803 DOI: 10.1152/physiolgenomics.00125.2007  0.88
2008 Bantubungi K, Blum D, Cuvelier L, Wislet-Gendebien S, Rogister B, Brouillet E, Schiffmann SN. Stem cell factor and mesenchymal and neural stem cell transplantation in a rat model of Huntington's disease. Molecular and Cellular Neurosciences. 37: 454-70. PMID 18083596 DOI: 10.1016/j.mcn.2007.11.001  0.88
2008 Charvin D, Roze E, Perrin V, Deyts C, Betuing S, Pagès C, Régulier E, Luthi-Carter R, Brouillet E, Déglon N, Caboche J. Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo. Neurobiology of Disease. 29: 22-9. PMID 17905594 DOI: 10.1016/J.Nbd.2007.07.028  0.88
2007 Escartin C, Boyer F, Bemelmans AP, Hantraye P, Brouillet E. IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats. Neuroscience Letters. 425: 167-72. PMID 17868993 DOI: 10.1016/J.Neulet.2007.08.031  0.88
2007 Escartin C, Pierre K, Colin A, Brouillet E, Delzescaux T, Guillermier M, Dhenain M, Déglon N, Hantraye P, Pellerin L, Bonvento G. Activation of astrocytes by CNTF induces metabolic plasticity and increases resistance to metabolic insults. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 7094-104. PMID 17611262 DOI: 10.1523/Jneurosci.0174-07.2007  0.88
2007 Palfi S, Brouillet E, Jarraya B, Bloch J, Jan C, Shin M, Condé F, Li XJ, Aebischer P, Hantraye P, Déglon N. Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 1444-51. PMID 17505477 DOI: 10.1038/Sj.Mt.6300185  0.88
2007 García-Martínez JM, Pérez-Navarro E, Xifró X, Canals JM, Díaz-Hernández M, Trioulier Y, Brouillet E, Lucas JJ, Alberch J. BH3-only proteins Bid and Bim(EL) are differentially involved in neuronal dysfunction in mouse models of Huntington's disease. Journal of Neuroscience Research. 85: 2756-69. PMID 17387706 DOI: 10.1002/Jnr.21258  0.88
2007 Perrin V, Régulier E, Abbas-Terki T, Hassig R, Brouillet E, Aebischer P, Luthi-Carter R, Déglon N. Neuroprotection by Hsp104 and Hsp27 in lentiviral-based rat models of Huntington's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 903-11. PMID 17375066 DOI: 10.1038/mt.sj.6300141  0.88
2007 Escartin C, Pierre K, Brouillet E, Delzescaux T, Guillermier M, Dhenain M, Deglon N, Hantraye P, Pellerin L, Bonvento G. CNTF-activated astrocytes display metabolic plasticity and increased resistance to metabolic insults Journal of Cerebral Blood Flow and Metabolism. 27: BP06-01M.  0.88
2006 Escartin C, Brouillet E, Gubellini P, Trioulier Y, Jacquard C, Smadja C, Knott GW, Kerkerian-Le Goff L, Déglon N, Hantraye P, Bonvento G. Ciliary neurotrophic factor activates astrocytes, redistributes their glutamate transporters GLAST and GLT-1 to raft microdomains, and improves glutamate handling in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 5978-89. PMID 16738240 DOI: 10.1523/Jneurosci.0302-06.2006  0.88
2006 Arango M, Holbert S, Zala D, Brouillet E, Pearson J, Régulier E, Thakur AK, Aebischer P, Wetzel R, Déglon N, Néri C. CA150 expression delays striatal cell death in overexpression and knock-in conditions for mutant huntingtin neurotoxicity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 4649-59. PMID 16641246 DOI: 10.1523/Jneurosci.5409-05.2006  0.88
2006 Borrell-Pagès M, Canals JM, Cordelières FP, Parker JA, Pineda JR, Grange G, Bryson EA, Guillermier M, Hirsch E, Hantraye P, Cheetham ME, Néri C, Alberch J, Brouillet E, Saudou F, et al. Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase. The Journal of Clinical Investigation. 116: 1410-24. PMID 16604191 DOI: 10.1172/Jci27607  0.88
2006 Jacquard C, Trioulier Y, Cosker F, Escartin C, Bizat N, Hantraye P, Cancela JM, Bonvento G, Brouillet E. Brain mitochondrial defects amplify intracellular [Ca2+] rise and neurodegeneration but not Ca2+ entry during NMDA receptor activation. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 1021-3. PMID 16571773 DOI: 10.1096/Fj.05-5085Fje  0.88
2006 Benchoua A, Trioulier Y, Zala D, Gaillard MC, Lefort N, Dufour N, Saudou F, Elalouf JM, Hirsch E, Hantraye P, Déglon N, Brouillet E. Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin. Molecular Biology of the Cell. 17: 1652-63. PMID 16452635 DOI: 10.1091/Mbc.E05-07-0607  0.88
2005 Brouillet E, Jacquard C, Bizat N, Blum D. 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease. Journal of Neurochemistry. 95: 1521-40. PMID 16300642 DOI: 10.1111/j.1471-4159.2005.03515.x  0.88
2005 Zala D, Benchoua A, Brouillet E, Perrin V, Gaillard MC, Zurn AD, Aebischer P, Déglon N. Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment. Neurobiology of Disease. 20: 785-98. PMID 16006135 DOI: 10.1016/J.Nbd.2005.05.017  0.88
2005 Bizat N, Galas MC, Jacquard C, Boyer F, Hermel JM, Schiffmann SN, Hantraye P, Blum D, Brouillet E. Neuroprotective effect of zVAD against the neurotoxin 3-nitropropionic acid involves inhibition of calpain. Neuropharmacology. 49: 695-702. PMID 15998526 DOI: 10.1016/j.neuropharm.2005.04.030  0.88
2005 Bantubungi K, Jacquard C, Greco A, Pintor A, Chtarto A, Tai K, Galas MC, Tenenbaum L, Déglon N, Popoli P, Minghetti L, Brouillet E, Brotchi J, Levivier M, Schiffmann SN, et al. Minocycline in phenotypic models of Huntington's disease. Neurobiology of Disease. 18: 206-17. PMID 15649711 DOI: 10.1016/j.nbd.2004.09.017  0.88
2004 Lastres-Becker I, Bizat N, Boyer F, Hantraye P, Fernández-Ruiz J, Brouillet E. Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo. Neuroreport. 15: 2375-9. PMID 15640759 DOI: 10.1097/00001756-200410250-00015  0.88
2004 Yang L, Sugama S, Mischak RP, Kiaei M, Bizat N, Brouillet E, Joh TH, Beal MF. A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo. Neurobiology of Disease. 17: 250-9. PMID 15474362 DOI: 10.1016/J.Nbd.2004.07.021  0.88
2004 Escartin C, Boyer F, Bemelmans AP, Hantraye P, Brouillet E. Insulin growth factor-1 protects against excitotoxicity in the rat striatum. Neuroreport. 15: 2251-4. PMID 15371744 DOI: 10.1097/00001756-200410050-00022  0.88
2004 Galas MC, Bizat N, Cuvelier L, Bantubungi K, Brouillet E, Schiffmann SN, Blum D. Death of cortical and striatal neurons induced by mitochondrial defect involves differential molecular mechanisms. Neurobiology of Disease. 15: 152-9. PMID 14751780 DOI: 10.1016/j.nbd.2003.09.013  0.88
2003 Bizat N, Hermel JM, Humbert S, Jacquard C, Créminon C, Escartin C, Saudou F, Krajewski S, Hantraye P, Brouillet E. In vivo calpain/caspase cross-talk during 3-nitropropionic acid-induced striatal degeneration: implication of a calpain-mediated cleavage of active caspase-3. The Journal of Biological Chemistry. 278: 43245-53. PMID 12917435 DOI: 10.1074/Jbc.M305057200  0.88
2003 Lastres-Becker I, Bizat N, Boyer F, Hantraye P, Brouillet E, Fernández-Ruiz J. Effects of cannabinoids in the rat model of Huntington's disease generated by an intrastriatal injection of malonate. Neuroreport. 14: 813-6. PMID 12858038 DOI: 10.1097/00001756-200305060-00007  0.88
2003 de Chaldée M, Gaillard MC, Bizat N, Buhler JM, Manzoni O, Bockaert J, Hantraye P, Brouillet E, Elalouf JM. Quantitative assessment of transcriptome differences between brain territories. Genome Research. 13: 1646-53. PMID 12840043 DOI: 10.1101/Gr.1173403  0.88
2003 Blum D, Galas MC, Pintor A, Brouillet E, Ledent C, Muller CE, Bantubungi K, Galluzzo M, Gall D, Cuvelier L, Rolland AS, Popoli P, Schiffmann SN. A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 5361-9. PMID 12832562  0.88
2003 Bizat N, Hermel JM, Boyer F, Jacquard C, Créminon C, Ouary S, Escartin C, Hantraye P, Kajewski S, Brouillet E. Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 5020-30. PMID 12832525 DOI: 10.1523/Jneurosci.23-12-05020.2003  0.88
2003 Stefanova N, Puschban Z, Fernagut PO, Brouillet E, Tison F, Reindl M, Jellinger KA, Poewe W, Wenning GK. Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: towards a model of striatonigral degeneration (multiple system atrophy). Acta Neuropathologica. 106: 157-66. PMID 12764627 DOI: 10.1007/S00401-003-0717-Y  0.88
2002 Henry PG, Lebon V, Vaufrey F, Brouillet E, Hantraye P, Bloch G. Decreased TCA cycle rate in the rat brain after acute 3-NP treatment measured by in vivo 1H-[13C] NMR spectroscopy. Journal of Neurochemistry. 82: 857-66. PMID 12358791 DOI: 10.1046/J.1471-4159.2002.01006.X  0.88
2002 Mittoux V, Ouary S, Monville C, Lisovoski F, Poyot T, Conde F, Escartin C, Robichon R, Brouillet E, Peschanski M, Hantraye P. Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 4478-86. PMID 12040055 DOI: 10.1523/Jneurosci.22-11-04478.2002  0.88
2002 Garcia M, Vanhoutte P, Pages C, Besson MJ, Brouillet E, Caboche J. The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-Jun N-terminal kinase/c-Jun module. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 2174-84. PMID 11896157 DOI: 10.1523/Jneurosci.22-06-02174.2002  0.88
2001 Bertrand E, Brouillet E, Caillé I, Bouillot C, Cole GM, Prochiantz A, Allinquant B. A short cytoplasmic domain of the amyloid precursor protein induces apoptosis in vitro and in vivo. Molecular and Cellular Neurosciences. 18: 503-11. PMID 11922141 DOI: 10.1006/Mcne.2001.1030  0.88
2001 El Massioui N, Ouary S, Chéruel F, Hantraye P, Brouillet E. Perseverative behavior underlying attentional set-shifting deficits in rats chronically treated with the neurotoxin 3-nitropropionic acid. Experimental Neurology. 172: 172-81. PMID 11681849 DOI: 10.1006/exnr.2001.7766  0.88
2000 Brouillet E. Animal models of Huntington's disease: from basic research on neuronal death to assessment of new therapeutic strategies. Functional Neurology. 15: 239-51. PMID 11213527  0.88
2000 Mittoux V, Joseph JM, Conde F, Palfi S, Dautry C, Poyot T, Bloch J, Deglon N, Ouary S, Nimchinsky EA, Brouillet E, Hof PR, Peschanski M, Aebischer P, Hantraye P. Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease. Human Gene Therapy. 11: 1177-87. PMID 10834619 DOI: 10.1089/10430340050015220  0.88
2000 Ouary S, Bizat N, Altairac S, Ménétrat H, Mittoux V, Condé F, Hantraye P, Brouillet E. Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies. Neuroscience. 97: 521-30. PMID 10828534 DOI: 10.1016/S0306-4522(00)00020-8  0.88
2000 Dautry C, Vaufrey F, Brouillet E, Bizat N, Henry PG, Condé F, Bloch G, Hantraye P. Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 20: 789-99. PMID 10826529 DOI: 10.1097/00004647-200005000-00005  0.88
2000 Kowall NW, Hantraye P, Brouillet E, Beal MF, McKee AC, Ferrante RJ. MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons. Neuroreport. 11: 211-3. PMID 10683860 DOI: 10.1097/00001756-200001170-00041  0.88
2000 Brouillet E, Peschanski M, Hantraye P. Toward understanding the molecular pathology of Huntington's disease | Du gene a la maladie: La mort neuronale dans la maladie de Huntington Medecine/Sciences. 16: 57-63.  0.88
1999 Brouillet E, Condé F, Beal MF, Hantraye P. Replicating Huntington's disease phenotype in experimental animals. Progress in Neurobiology. 59: 427-68. PMID 10515664 DOI: 10.1016/S0301-0082(99)00005-2  0.88
1999 Dautry C, Condé F, Brouillet E, Mittoux V, Beal MF, Bloch G, Hantraye P. Serial 1H-NMR spectroscopy study of metabolic impairment in primates chronically treated with the succinate dehydrogenase inhibitor 3-nitropropionic acid. Neurobiology of Disease. 6: 259-68. PMID 10448053 DOI: 10.1006/Nbdi.1999.0244  0.88
1999 Ferrante RJ, Hantraye P, Brouillet E, Beal MF. Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthase. Brain Research. 823: 177-82. PMID 10095024 DOI: 10.1016/S0006-8993(99)01166-X  0.88
1999 Brouillet E, Trembleau A, Galanaud D, Volovitch M, Bouillot C, Valenza C, Prochiantz A, Allinquant B. The amyloid precursor protein interacts with Go heterotrimeric protein within a cell compartment specialized in signal transduction. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 1717-27. PMID 10024358 DOI: 10.1523/Jneurosci.19-05-01717.1999  0.88
1998 Palfi S, Condé F, Riche D, Brouillet E, Dautry C, Mittoux V, Chibois A, Peschanski M, Hantraye P. Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease. Nature Medicine. 4: 963-6. PMID 9701252 DOI: 10.1038/Nm0898-963  0.88
1998 Brouillet E, Guyot MC, Mittoux V, Altairac S, Condé F, Palfi S, Hantraye P. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. Journal of Neurochemistry. 70: 794-805. PMID 9453576 DOI: 10.1046/J.1471-4159.1998.70020794.X  0.88
1997 Guyot MC, Palfi S, Stutzmann JM, Mazière M, Hantraye P, Brouillet E. Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats. Neuroscience. 81: 141-9. PMID 9300407 DOI: 10.1016/S0306-4522(97)00192-9  0.88
1997 Palfi S, Riche D, Brouillet E, Guyot MC, Mary V, Wahl F, Peschanski M, Stutzmann JM, Hantraye P. Riluzole reduces incidence of abnormal movements but not striatal cell death in a primate model of progressive striatal degeneration. Experimental Neurology. 146: 135-41. PMID 9225746 DOI: 10.1006/Exnr.1997.6520  0.88
1997 Guyot MC, Hantraye P, Dolan R, Palfi S, Maziére M, Brouillet E. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid. Neuroscience. 79: 45-56. PMID 9178864 DOI: 10.1016/S0306-4522(96)00602-1  0.88
1997 Bottlaender M, Schmid L, Fuseau C, Fournier D, Brouillet E, Mazière M. In vivo modulation of benzodiazepine receptor function after inhibition of endogenous gamma-aminobutyyric acid synthesis. European Journal of Pharmacology. 321: 13-7. PMID 9083780 DOI: 10.1016/S0014-2999(97)00004-6  0.88
1996 Roeda D, Crouzel C, Brouillet E, Valette H. Synthesis and in vivo distribution of no-carrier-added N(omega)-Nitro-L-arginine [11C]methyl ester, a nitric oxide synthase inhibitor. Nuclear Medicine and Biology. 23: 509-12. PMID 8832708 DOI: 10.1016/0969-8051(96)00032-7  0.88
1996 Schmid L, Bottlaender M, Brouillet E, Fuseau C, Mazière M. Vigabatrin modulates benzodiazepine receptor activity in vivo: a positron emission tomography study in baboon. The Journal of Pharmacology and Experimental Therapeutics. 276: 977-83. PMID 8786578  0.88
1996 Hantraye P, Brouillet E, Ferrante R, Palfi S, Dolan R, Matthews RT, Beal MF. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nature Medicine. 2: 1017-21. PMID 8782460 DOI: 10.1038/nm0996-1017  0.88
1996 Palfi S, Ferrante RJ, Brouillet E, Beal MF, Dolan R, Guyot MC, Peschanski M, Hantraye P. Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 3019-25. PMID 8622131 DOI: 10.1523/Jneurosci.16-09-03019.1996  0.88
1996 Jenkins BG, Brouillet E, Chen YC, Storey E, Schulz JB, Kirschner P, Beal MF, Rosen BR. Non-invasive neurochemical analysis of focal excitotoxic lesions in models of neurodegenerative illness using spectroscopic imaging. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 16: 450-61. PMID 8621749 DOI: 10.1097/00004647-199605000-00011  0.88
1995 Brouillet E, Hantraye P. Effects of chronic MPTP and 3-nitropropionic acid in nonhuman primates. Current Opinion in Neurology. 8: 469-73. PMID 8845934 DOI: 10.1097/00019052-199512000-00014  0.88
1995 Brouillet E, Roeda D, Valette H, Fuseau C, Guyot MC, Crouzel C. In vivo metabolites of N omega-nitro-L-arginine methyl ester: methanol and N omega-nitro-L-arginine. European Journal of Pharmacology. 293: 487-90. PMID 8748703 DOI: 10.1016/0926-6917(95)90070-5  0.88
1995 Brouillet E, Hantraye P, Ferrante RJ, Dolan R, Leroy-Willig A, Kowall NW, Beal MF. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proceedings of the National Academy of Sciences of the United States of America. 92: 7105-9. PMID 7624378 DOI: 10.1073/Pnas.92.15.7105  0.88
1995 Schmid L, Bottlaender M, Fuseau C, Fournier D, Brouillet E, Mazière M. Zolpidem displays heterogeneity in its binding to the nonhuman primate benzodiazepine receptor in vivo. Journal of Neurochemistry. 65: 1880-6. PMID 7561888 DOI: 10.1046/J.1471-4159.1995.65041880.X  0.88
1994 Bottlaender M, Brouillet E, Varastet M, Le Breton C, Schmid L, Fuseau C, Sitbon R, Crouzel C, Mazière M. In vivo high intrinsic efficacy of triazolam: a positron emission tomography study in nonhuman primates. Journal of Neurochemistry. 62: 1102-11. PMID 8113798 DOI: 10.1046/J.1471-4159.1994.62031102.X  0.88
1994 Brouillet E, Henshaw DR, Schulz JB, Beal MF. Aminooxyacetic acid striatal lesions attenuated by 1,3-butanediol and coenzyme Q10. Neuroscience Letters. 177: 58-62. PMID 7824183 DOI: 10.1016/0304-3940(94)90044-2  0.88
1994 Brouillet E, Hyman BT, Jenkins BG, Henshaw DR, Schulz JB, Sodhi P, Rosen BR, Beal MF. Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism. Experimental Neurology. 129: 175-82. PMID 7525331 DOI: 10.1006/Exnr.1994.1159  0.88
1994 Hantraye P, Brouillet E. Chronic treatment with mitochondrial toxins in primates as experimental models of Parkinson's and Huntington's diseases Circulation Et Metabolisme Du Cerveau. 11: 311-326.  0.88
1993 Brouillet E, Beal MF. NMDA antagonists partially protect against MPTP induced neurotoxicity in mice. Neuroreport. 4: 387-90. PMID 8499594 DOI: 10.1097/00001756-199304000-00011  0.88
1993 Delforge J, Syrota A, Bottlaender M, Varastet M, Loc'h C, Bendriem B, Crouzel C, Brouillet E, Maziere M. Modeling analysis of [11C]flumazenil kinetics studied by PET: application to a critical study of the equilibrium approaches. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 13: 454-68. PMID 8478404 DOI: 10.1038/jcbfm.1993.60  0.88
1993 Brouillet EP, Shinobu L, McGarvey U, Hochberg F, Beal MF. Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism. Experimental Neurology. 120: 89-94. PMID 8477830 DOI: 10.1006/exnr.1993.1042  0.88
1993 Brouillet E, Jenkins BG, Hyman BT, Ferrante RJ, Kowall NW, Srivastava R, Roy DS, Rosen BR, Beal MF. Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. Journal of Neurochemistry. 60: 356-9. PMID 8417157 DOI: 10.1111/J.1471-4159.1993.Tb05859.X  0.88
1993 Wüllner U, Brouillet E, Isacson O, Young AB, Penney JB. Glutamate receptor binding sites in MPTP-treated mice. Experimental Neurology. 121: 284-7. PMID 8393409 DOI: 10.1006/exnr.1993.1098  0.88
1993 Srivastava R, Brouillet E, Beal MF, Storey E, Hyman BT. Blockade of 1-methyl-4-phenylpyridinium ion (MPP+) nigral toxicity in the rat by prior decortication or MK-801 treatment: a stereological estimate of neuronal loss. Neurobiology of Aging. 14: 295-301. PMID 8103573 DOI: 10.1016/0197-4580(93)90114-Q  0.88
1993 Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 13: 4181-92. PMID 7692009  0.88
1993 Beal MF, Brouillet E, Jenkins B, Henshaw R, Rosen B, Hyman BT. Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. Journal of Neurochemistry. 61: 1147-50. PMID 7689641 DOI: 10.1111/J.1471-4159.1993.Tb03633.X  0.88
1992 Storey E, Hyman BT, Jenkins B, Brouillet E, Miller JM, Rosen BR, Beal MF. 1-Methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism. Journal of Neurochemistry. 58: 1975-8. PMID 1560246 DOI: 10.1111/J.1471-4159.1992.Tb10080.X  0.88
1992 Varastet M, Brouillet E, Chavoix C, Prenant C, Crouzel C, Stulzaft O, Bottlaender M, Cayla J, Mazière B, Mazière M. In vivo visualization of central muscarinic receptors using [11C]quinuclidinyl benzilate and positron emission tomography in baboons. European Journal of Pharmacology. 213: 275-84. PMID 1521561 DOI: 10.1016/0014-2999(92)90692-W  0.88
1992 Chavoix C, Brouillet E, Hantraye P, de la Sayette V, Kunimoto M, Varastet M, Guibert B, Dodd RH, Fournier D, Naquet R. In vivo interactions of pentylenetetrazole with benzodiazepine receptors: lack of direct correlation between benzodiazepine receptor occupancy and convulsant potency of this drug. Epilepsy Research. Supplement. 8: 351-9. PMID 1329823  0.88
1991 de la Sayette V, Chavoix C, Brouillet E, Hantraye P, Kunimoto M, Khalili-Varasteh M, Guibert B, Prenant C, Mazière M. In vivo benzodiazepine receptor occupancy by CL 218,872 visualized by positron emission tomography in the brain of the living baboon: modulation by GABAergic transmission and relation with anticonvulsant activity. Experimental Brain Research. 83: 397-402. PMID 1673661 DOI: 10.1007/Bf00231164  0.88
1991 Brouillet E, Chavoix C, Bottlaender M, Khalili-Varasteh M, Hantraye P, Fournier D, Dodd RH, Mazière M. In vivo bidirectional modulatory effect of benzodiazepine receptor ligands on GABAergic transmission evaluated by positron emission tomography in non-human primates. Brain Research. 557: 167-76. PMID 1660750 DOI: 10.1016/0006-8993(91)90131-E  0.88
1991 Chavoix C, Brouillet E, Kunimoto M, De la Sayette V, Khalili-Varasteh M, Hantraye P, Dodd RH, Guibert B, Prenant C, Naquet R. Relationships between benzodiazepine receptors, impairment of GABAergic transmission and convulsant activity of beta-CCM: a PET study in the baboon Papio papio. Epilepsy Research. 8: 1-10. PMID 1647949 DOI: 10.1016/0920-1211(91)90030-J  0.88
1991 Loc'h C, Hantraye P, Khalili-Varasteh M, Maziere B, Delforge J, Brouillet E, Syrota A, Maziere M. [11C]-Flumazenil metabolites: Measurements of unchanged ligand in plasma using thin layer chromatography and rapid liquid chromatography Journal of Labelled Compounds and Radiopharmaceuticals. 30: 234.  0.88
1990 Yamaguchi T, Kunimoto M, Pappata S, Chavoix C, Brouillet E, Riche D, Mazière M, Naquet R, MacKenzie ET, Baron JC. Effects of unilateral lesion of the nucleus basalis of Meynert on brain glucose utilization in callosotomized baboons: a PET study. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 10: 618-23. PMID 2384534 DOI: 10.1038/Jcbfm.1990.113  0.88
1990 Brouillet E, Chavoix C, Khalili-Varasteh M, Bottlaender M, Hantraye P, Yorke JC, Maziere M. Quantitative evaluation of benzodiazepine receptors in live Papio papio baboons using positron emission tomography. Molecular Pharmacology. 38: 445-50. PMID 2172764  0.88
1990 Brouillet E, Chavoix C, Hantraye P, Kunimoto M, Khalili-Varasteh M, Chevalier P, Frydman A, Gaillot J, Prenant C, Crouzel M. Interaction of suriclone with central type benzodiazepine receptors in living baboons. European Journal of Pharmacology. 175: 49-55. PMID 1969798  0.88
1989 Brouillet E, Chavoix C, de la Sayette V, Hantraye P, Kunimoto M, Khalili-Varasteh M, Guibert B, Fournier D, Dodd RH, Naquet R. Anticonvulsant activity of the diaryltriazine, LY81067: studies using electroencephalographic recording and positron emission tomography. Neuropharmacology. 28: 351-8. PMID 2501707 DOI: 10.1016/0028-3908(89)90029-4  0.88
1988 Hantraye P, Brouillet E, Fukuda H, Chavoix C, Guibert B, Dodd RH, Prenant C, Crouzel M, Naquet R, Mazière M. Benzodiazepine receptors studied in living primates by positron emission tomography: antagonist interactions. European Journal of Pharmacology. 153: 25-32. PMID 2905664 DOI: 10.1016/0014-2999(88)90584-5  0.88
1988 Chavoix C, Hantraye P, Brouillet E, Guibert B, Fukuda H, De la Sayette V, Fournier D, Naquet R, Mazière M. Status epilepticus induced by pentylenetetrazole modulates in vivo [11C]Ro 15-1788 binding to benzodiazepine receptors. Effects of ligands acting at the supramolecular receptor complex. European Journal of Pharmacology. 146: 207-14. PMID 2836206 DOI: 10.1016/0014-2999(88)90294-4  0.88
1987 Hantraye P, Chavoix C, Guibert B, Fukuda H, Brouillet E, Dodd RH, Prenant C, Crouzel M, Naquet R, Mazière M. Benzodiazepine receptors studied in living primates by positron emission tomography: inverse agonist interactions. European Journal of Pharmacology. 138: 239-47. PMID 3040433 DOI: 10.1016/0014-2999(87)90438-9  0.88
1987 Hantraye P, Brouillet E, Chavoix C, Guibert B, de la Sayette V, Naquet R, Mazière M. [Study of specific binding sites of benzodiazepines using positron emission tomography in live baboons (Papio papio)]. Thã©Rapie. 42: 493-8. PMID 2831635  0.88
1987 Hantraye P, Brouillet E, Guibert B, Chavoix C, Fukuda H, Prenant C, Crouzel M, Naquet R, Maziere M. Pentylenetetrazol-induced seizure is not mediated by benzodiazepine receptors in vivo. Neuropharmacology. 26: 1509-12. PMID 2825060 DOI: 10.1016/0028-3908(87)90171-7  0.88
Show low-probability matches.